Fangzhou Li
- Co-authors
- Wenhui ZhaoHai‐Chao HanQianqian SunK. LiuNing LinFeng TianZebin MaoTanjun Tong
- Topics
- Cardiac Valve Diseases and Treatments (2 papers)Cancer, Hypoxia, and Metabolism (2 papers)Epigenetics and DNA Methylation (2 papers)
- Partner nations
- ChinaUnited StatesUnited Kingdom
In The Last Decade
Fangzhou Li
18 papers receiving 321 citations
Peers
Comparison fields: 5 of 82
- Molecular Biology 168
- Physiology 65
- Cancer Research 49
- Pharmaceutical Science 32
- Oncology 30
Countries citing papers authored by Fangzhou Li
This map shows the geographic impact of Fangzhou Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fangzhou Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fangzhou Li more than expected).
Fields of papers citing papers by Fangzhou Li
This network shows the impact of papers produced by Fangzhou Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fangzhou Li. The network helps show where Fangzhou Li may publish in the future.
Co-authorship network of co-authors of Fangzhou Li
This figure shows the co-authorship network connecting the top 25 collaborators of Fangzhou Li. A scholar is included among the top collaborators of Fangzhou Li based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Fangzhou Li. Fangzhou Li is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 8 | |
| 2 | 0 | |
| 3 | 3 | |
| 4 | 1 | |
| 5 | 2 | |
| 6 | 41 | |
| 7 | 3 | |
| 8 | 6 | |
| 9 | 1 | |
| 10 | 14 | |
| 11 | 8 | |
| 12 | 22 | |
| 13 | 40 | |
| 14 | 17 | |
| 15 | 116 | |
| 16 | 27 | |
| 17 | 1 | |
| 18 | 1 | |
| 19 | 13 |
About Fangzhou Li
Fangzhou Li is a scholar working on Nephrology, Complementary and alternative medicine and Dermatology, having authored 19 papers that have together received 324 indexed citations. Recurring topics across this work include Cardiac Valve Diseases and Treatments (2 papers), Cancer, Hypoxia, and Metabolism (2 papers) and Epigenetics and DNA Methylation (2 papers). The work is most often cited by research in Pharmaceutical Science (32 citations), Cancer Research (49 citations) and Geriatrics and Gerontology (11 citations). Fangzhou Li has collaborated with scholars based in China, United States and United Kingdom. Frequent co-authors include Wenhui Zhao, Hai‐Chao Han, Qianqian Sun, K. Liu, Ning Lin, Feng Tian, Zebin Mao, Tanjun Tong, Kaiqiang You and Wei Gu. Their work appears in journals such as Cellular and Molecular Life Sciences, Experimental Cell Research and Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.